Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shoemaker

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
Journal of Medicinal Chemistry|October 10, 2008
Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteinsCheol-Min Park, Milan Bruncko, Jessica Adickes, et al.
Journal of Medicinal Chemistry|August 20, 2004
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancerThorsten K Oost, Chaohong Sun, Robert C Armstrong, et al.
Molecular Cancer Therapeutics|September 15, 2011
The Bcl-2/Bcl-X(L)/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivoJun Chen, Sha Jin, Vivek Abraham, et al.
Journal of Medicinal Chemistry|July 14, 2018
Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315Clarissa G Jakob, Anup K Upadhyay, Pamela L Donner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2011
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitorXuesong Liu, Yan Shi, David X Maag, et al.
Viruses|July 30, 2025
Rift Valley Fever Outbreak Investigation Associated with a Dairy Farm Abortion Storm, Mbarara District, Western Uganda, 2023Luke Nyakarahuka, Shannon Whitmer, Sophia Mulei, et al.
ACS Chemical Biology|February 21, 2022
The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for ImmunotherapySven Malchow, Alla Korepanova, Sanjay C Panchal, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Atypical hyperendemicity of Rift Valley fever in Southwestern Uganda associated with the rapidly evolving lineage C virusesBarnabas Bakamutumaho, John Juma, Erin Clancey, et al.
Journal of Medicinal Chemistry|February 3, 2006
Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivoMichael D Wendt, Wang Shen, Aaron Kunzer, et al.
Journal of Medicinal Chemistry|January 30, 2007
Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xLMilan Bruncko, Thorsten K Oost, Barbara A Belli, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Journal of Medicinal Chemistry|October 10, 2008
Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteinsCheol-Min Park, Milan Bruncko, Jessica Adickes, et al.
Journal of Medicinal Chemistry|August 20, 2004
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancerThorsten K Oost, Chaohong Sun, Robert C Armstrong, et al.
Molecular Cancer Therapeutics|September 15, 2011
The Bcl-2/Bcl-X(L)/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivoJun Chen, Sha Jin, Vivek Abraham, et al.
Journal of Medicinal Chemistry|July 14, 2018
Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315Clarissa G Jakob, Anup K Upadhyay, Pamela L Donner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2011
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitorXuesong Liu, Yan Shi, David X Maag, et al.
Viruses|July 30, 2025
Rift Valley Fever Outbreak Investigation Associated with a Dairy Farm Abortion Storm, Mbarara District, Western Uganda, 2023Luke Nyakarahuka, Shannon Whitmer, Sophia Mulei, et al.
ACS Chemical Biology|February 21, 2022
The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for ImmunotherapySven Malchow, Alla Korepanova, Sanjay C Panchal, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Atypical hyperendemicity of Rift Valley fever in Southwestern Uganda associated with the rapidly evolving lineage C virusesBarnabas Bakamutumaho, John Juma, Erin Clancey, et al.
Journal of Medicinal Chemistry|February 3, 2006
Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivoMichael D Wendt, Wang Shen, Aaron Kunzer, et al.
Journal of Medicinal Chemistry|January 30, 2007
Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xLMilan Bruncko, Thorsten K Oost, Barbara A Belli, et al.
Pageof 17